Mental Practice and Therapeutic Exercise in Young Nulliparous Women

Mental Practice and Therapeutic Exercise in Young Nulliparous Women: A Randomized Controlled Trial

Mental practice (both in isolation and also in combination with real practice) has been shown to improve somatosensory and motor variables but so far no study has taken it into the study of women's health. Through this study we want to offer some interesting data regarding the effectiveness of mental practice combined with physical practice.

Study Overview

• Status: Recruiting
• Conditions: Motor Imagery; Therapeutic Exercise; Action Observation
• Intervention / Treatment: Behavioral: Motor Imagery plus therapeutic exercise; Behavioral: Action observation plus therapeutic exercise; Behavioral: Sham action observation plus therapeutic exercise

• Study Type: Interventional
• Enrollment (Estimated): 45
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Ferran Cuenca Martinez, PhD; Phone Number: 913456781; Email: ferran.cuenca@uv.es

Study Locations

• Spain
  • Valencia, Spain, 46017
    • Recruiting
    • Ferran Cuenca Martínez
    • Contact: Ferran Cuenca Martinez, PhD; Phone Number: 913456781; Email: ferran.cuenca@uv.es

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• over 18 years of age and asymptomatic women.

Exclusion Criteria:

• This study will exclude those who presented a respiratory pathology, cardiac, systematic, or metabolic disease, history of recent surgery, vertebral fracture, or osteoarticular disorders of the spine area.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Therapeutic exercise plus motor imagery; This group will perform a therapeutic exercise programme (aerobic and strength training) to which motor imagery training will be added.	Behavioral: Motor Imagery plus therapeutic exercise; Aerobic exercise (20 minutes) and strengthening exercise (15 minutes) to which will be added a motor imagery intervention (imagining movements without actually doing them).
Experimental: Therapeutic exercise plus action observation; This group will perform a therapeutic exercise programme (aerobic and strength training) to which action observation training will be added.	Behavioral: Action observation plus therapeutic exercise; Aerobic exercise (20 minutes) and strengthening exercise (15 minutes) to which will be added a action observation intervention (observing movements without actually doing them).
Active Comparator: Therapeutic exercise; This group will perform a therapeutic exercise programme (aerobic and strength training) to which sham action observation training will be added.	Behavioral: Sham action observation plus therapeutic exercise; Aerobic exercise (20 minutes) and strengthening exercise (15 minutes) to which will be added a sham action observation intervention (observing space planets).

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pelvic Floor Muscle Strength	maximum pelvic floor strength	pre-intervention (T0), and inmmediate post-intervention (T1) (between the first and the second measurement, about 60 minutes have elapsed because it is done on the same day).
Pain Pressure Threshold	Pain sensitivity	pre-intervention (T0), and inmmediate post-intervention (T1) (between the first and the second measurement, about 60 minutes have elapsed because it is done on the same day).
Lumbopelvic Motor Control	Sensorimotor control of lower limbs	pre-intervention (T0), and inmmediate post-intervention (T1) (between the first and the second measurement, about 60 minutes have elapsed because it is done on the same day).

Collaborators and Investigators

• Sponsor: University of Valencia

Study record dates

Study Major Dates

• Study Start (Actual): September 30, 2023
• Primary Completion (Estimated): April 30, 2024
• Study Completion (Estimated): April 30, 2024

Study Registration Dates

• First Submitted: October 3, 2023
• First Submitted That Met QC Criteria: October 3, 2023
• First Posted (Actual): October 10, 2023

Study Record Updates

• Last Update Posted (Actual): October 23, 2023
• Last Update Submitted That Met QC Criteria: October 19, 2023
• Last Verified: October 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: UV0001

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No